2010’s

• 2019

  Attracted the third round external capital funding.

• 2018

  Established MOU with Korea Atomic Energy Research Institute (KAERI), Yonsei University
  (Department of Pharmacy), and Chonnam National University (College of Veterinary Medicin).

• 2017

  Established MOU with Asan Medical center and Konkuk University Bioimaging Center.
  Attracted the second round external capital funding.

• 2016

  Attracted the first round external capital funding.

• 2015

  Change company name to BioActs, secure external fund.
  Established distributorship agreement and MOU with Seoulin Bioscience Inc.

• 2014

  Selected as a member of K-club of Korea Institute of Science and Technology.

• 2013

  Recognized as a Visionary Company by Incheon Metropolitan city.
  Established MOU between BioActs and National Institute of Imaging and
  Bioengineering, an affiliated institute of NIH.

• 2012

  Biological division business marketing and sales launched.
  Established MOU with Chonnam National University Hwasun Hospital.

• 2010

  Certified as an Advanced Technology Center (ATC) for biomolecular labeling materials.
  The New Excellent Technology (NET) certification acquired

2000’s

• 2009

  Biological business division (BioActs) established.

• 2005

  Antibacterial dyes and blue fluorescent OLED material production begin.

• 2002

  Ningbo Factory and Hangzhou Sales Corporation in China launched.

• 2001

  Awarded the presidential commendation and 5 million dollars export tower.

1990’s

• 1991

  Affiliated R&D center established; opened an era of innovative growth.

• 1976

  Corporation established; opened an era of creation and exploration.